Home » Topics » BioWorld Science

BioWorld Science
RSS

Biopolar Hongye presents new Janus kinase inhibitors

Dec. 21, 2021

GTPase KRAS mutant inhibitors patented by Genfleet Therapeutics

Dec. 21, 2021

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

Dec. 21, 2021

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Dec. 21, 2021

Hongyun Biotech identifies new EGFR inhibitors

Dec. 21, 2021

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Dec. 20, 2021

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Dec. 20, 2021

SRSF1 is a therapeutic target for the treatment of breast cancer

Dec. 20, 2021

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

Dec. 20, 2021

PFKFB3 targeting shows promise for treating breast cancer

Dec. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...